AN
44
-6
IFF
44
-3
NVDA
56
4
ZTS
27
2
FAST
48
3
DO
49
-5
HSY
41
-2
CTAS
53
4
OKE
73
2
MRK
58
7
STI
75
29
PM
49
-23
LRCX
45
5
FLR
55
2
MCHP
62
3
ETN
82
-2
MDT
53
-3
VMC
71
3
IPG
50
-3
EIX
56
2
AN
44
-6
IFF
44
-3
NVDA
56
4
ZTS
27
2
FAST
48
3
DO
49
-5
HSY
41
-2
CTAS
53
4
OKE
73
2
MRK
58
7
STI
75
29
PM
49
-23
LRCX
45
5
FLR
55
2
MCHP
62
3
ETN
82
-2
MDT
53
-3
VMC
71
3
IPG
50
-3
EIX
56
2
Financhill
Back

Aadi Bioscience 10K Form

Sell
37

AADI
Aadi Bioscience

Last Price:
1.68
Seasonality Move:
27.16%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive AADI News And Ratings

See the #1 stock for the next 7 days that we like better than AADI

AADI Financial Statistics

Sales & Book Value

Annual Sales: $24.35M
Cash Flow: $-10.46M
Price / Cash Flow: 0
Annual Sales: $4.28
Price / Book: 0.39

Profitability

EPS (TTM): -2.44000
Net Income (TTM): $-65.77M
Gross Margin: $21.55M
Return on Equity: -49.88%
Return on Assets: -42.26%

Aadi Bioscience Earnings Forecast

Key Aadi Bioscience Financial Ratios

  • The Gross Profit Margin over the past 3 years for AADI is 88.47%.
  • The Selling, General & Administrative Expenses for AADI have been equal to 182.92% of Gross Profit Margin.
  • The Research & Development expenses have been 200.91% of Revenue.
  • The Interest Expense is -0.35% of Operating Income.
  • The Net Earning history of AADI is -270.04% of Total Revenues.
  • Per Share Earnings over the last 4 years have been positive in 2 years.

Aadi Bioscience Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: AADI
Website: aadibio.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 4.72
Quick Ratio: 4.33

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

AADI Technical Analysis vs Fundamental Analysis

Sell
37
Aadi Bioscience (AADI) is a Sell

Is Aadi Bioscience a Buy or a Sell?

  • Aadi Bioscience stock is rated a Sell
    The current Aadi Bioscience [AADI] share price is $1.68. The Score for AADI is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.